The hidden cost GLP boom shows total payments rose sharply from 2017-2022 despite lower out-of-pocket costs, impacting insurers and Medicare programs.

Thousands of people in England and Wales with a type of chronic heart failure (CHF) could soon be eligible for treatment with ...

Preclinical evidence positions ammonia-mediated intestinal barrier disruption as a proximal driver of MASH via gut-derived toxin influx and downstream immune activation, including hyperactive CD8+ T ...

Apnimed has joined the IPO queue on the Nasdaq, hoping to raise additional funding for its late-stage oral therapy for ...

A wave of new research and policy developments is reshaping how health system leaders think about GLP-1 medications — from telehealth prescribing gaps to Medicare’s new coverage bridge. Here are six ...

Employers increasingly steer weight-loss GLP-1 access to direct-to-consumer subscriptions, sometimes funding HSAs/FSAs instead of adding formal plan coverage. Coverage remains diabetes-centric: 60% ...

New research has analysed the proportion of patients aged 80 and over without disease who go on to develop referable ...

FatPipe, Inc. ("FatPipe" or the "Company"), a pioneer in enterprise-class software-defined wide area networking and cybersecurity solutions, is pleased to announce that it will host an investor ...

Spread the love“`html Managing diabetes effectively requires a multifaceted approach that includes lifestyle changes, ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through ...

Tune in to the latest EMJ Webinar, exploring holistic diabetes care through the practical and evidence-based Alphabet Strategy. Guest speaker Vinod Patel shares expert insights into delivering ...